Quarterly report pursuant to Section 13 or 15(d)

Licenses Acquired (Tables)

v3.21.2
Licenses Acquired (Tables)
9 Months Ended
Sep. 30, 2021
Licenses Acquired  
Schedule of Research and Development-Licenses

Three Months Ended September 30, 

Nine Months Ended September 30, 

($ in thousands)

    

2021

    

2020

    

2021

    

2020

Partner companies:

 

  

 

  

 

  

 

  

JMC

$

76

$

$

13,819

$

Mustang

630

287

1,630

1,837

Aevitas

7

162

34

162

Baergic

 

 

8

 

 

8

Oncogenuity

1

1

271

FBIO Acquisition Corp VIII

101

Total

$

713

$

458

$

15,585

$

2,278

Schedule of Research and Development for Licenses Acquired

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

($ in thousands)

    

2021

    

2020

    

2021

    

2020

City of Hope National Medical Center

CD123 (MB-102)

$

$

$

250

$

334

IL13Rα2 (MB-101)

333

HER2 (MB-103)

250

PSCA (MB-105)

250

 

250

 

Spacer

333

Mayo Clinic

750

Fred Hutchinson Cancer Research Center - CD20 (MB-106)

300

Leiden University Medical Centre

350

350

CSL Behring (Calimmune)

30

170

30

170

SIRION Biotech LentiBOOSTTM

117

117

Total

$

630

$

287

$

1,630

$

1,837